Compliance
A Brief Regulatory History of Process Validation
By Mark Land, AAHP President Finished product testing is probabilistic and not dispositive of process control; that is why we need process validation. While preparing this article I came…
Read MoreThe Case for Process Validation
By Mark Land, AAHP President The Homeopathic Pharmacopoeia of the United States says: “Dosage Forms – These, like all other conditions of homeopathic production should be governed by simplicity…
Read MoreThe British Homœopathic Pharmacopœia
By Eric Foxman, AAHP Secretary A quick look at its history, purpose, and contents, as well as the potential for adulteration and misbranding violations in the U.S. market. readm more…
Read MoreHealth Care Product Recalls
By Mark Land, AAHP President July 1, 2018 Product recalls are an important tool for manufacturers and the Food and Drug Administration (FDA) to minimize exposure to potentially harmful or…
Read MoreLatest Updates to the HPUS
By Eric L. Foxman, Senior Scientist, HPCUS, AAHP secretary June 4, 2018 Of all the changes implemented by the Homeopathic Pharmacopoeia Convention of the United States (HPCUS) in the past…
Read MoreAAHP Speaking Tour
By Mark Land, AAHP President April 24, 2018 Since the beginning of the year I have embarked on a tour to inform the community of AAHP’s position on the FDA’s…
Read MoreThe German Homeopathic Pharmacopeia
By Eric Foxman, AAHP secretary February 1, 2018 A quick look at its history, purpose and contents, as well as the potential for adulteration and misbranding violations in the United…
Read MoreProminence in Advertising and Labeling
By Mark Land, AAHP president February 1, 2018 A search under the term “prominence” yields 43 citations within Title 21 of the U.S. Code of Federal Regulations.1 Prominence appears 11…
Read MoreTesting the New AAHP Disclaimer for Effectiveness
By Jeremy Kees, PhD, Professor, Marketing & Business Law and Faculty Director, Villanova University February 1, 2018 The American Association of Homeopathic Pharmacists (AAHP) enlisted my assistance in 2017 to…
Read MoreNew Drug Listing Requirement and Timetable Effective this Month
By Eric Foxman, AAHP Secretary October 1, 2017 The FDA recently introduced new requirements for the annual drug product reporting period and a new Structured Product Labeling (SPL) submission type.…
Read More